Manuel Guzman-Cannabinoides y Cancer/g

CANNABINOIDES Y CÁNCER
Manuel Guzmán
BIBLIOGRAFÍA
Cannabinoides y sus receptores
Katona, I., Freund, T.F. Endocannabinoid signaling as a synaptic circuit breaker in neurological
disease. Nat. Med. 14, 923-930 (2008).
Pacher, P., Batkai, S., Kunos, G. The endocannabinoid system as an emerging target of
pharmacotherapy. Pharmacol. Rev. 58, 389-462 (2006).
Pertwee, R.G. Emerging strategies for exploiting cannabinoid receptor agonists as medicines.
Br. J. Pharmacol. 156, 397-411 (2009).
Pertwee, R.G., Howlett, A.C., Abood, M.E., Alexander, S.P., Di Marzo, V., Elphick, M.R.,
Greasley, P.J., Hansen, H.S., Kunos, G., Mackie, K., Mechoulam, R., Ross, R.A.
International Union of Pharmacology. LXXIX. Cannabinoid receptors and their ligands:
beyond CB1 and CB2. Pharmacol. Rev. 62, 588-631 (2010).
Acciones paliativas de los cannabinoides en Oncología
Engels, F.K., de Jong, F.A., Mathijssen, R.H., Erkens, J.A., Herings, R.M., Verweij, J. Medicinal
cannabis in oncology. Eur. J. Cancer. 43, 2638-2644 (2007).
Hall, W., Christie, M., Currow, D. Cannabinoids and cancer: causation, remediation, and
palliation. Lancet Oncol. 6, 35-42 (2005).
Machado Rocha, F.C., Stéfano, S.C., De Cássia Haiek, R., Rosa Oliveira, L.M., Da Silveira,
D.X. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting
among cancer patients: systematic review and meta-analysis. Eur. J. Cancer Care 17, 431443 (2008).
Slatkin, N.E. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting:
beyond prevention of acute emesis. J. Support. Oncol. 5, 1-9 (2007).
Acción antitumoral de los cannabinoides
Alexander, A., Smith, P.F., Rosengren, R.J. Cannabinoids in the treatment of cancer. Cancer
Lett. 285, 6-12 (2009).
Carracedo, A., Lorente, M., Egia, A., Blázquez, C., Garcia, S., Giroux, V., Malicet, C.,
Villuendas, R., Gironella, M., González-Feria, L., Piris, M.A., Iovanna, J.L., Guzmán, M.,
Velasco, G. The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of
tumor cells. Cancer Cell 9, 301-312 (2006).
Flygare, J., Sander, B. The endocannabinoid system in cancer - potential therapeutic target?
Semin. Cancer Biol. 18, 176-189 (2008).
Guzmán, M. Cannabinoids: potential anticancer agents. Nat. Rev. Cancer 3, 745-755 (2003).
Guzmán, M., Duarte, M.J., Blázquez, C., Ravina, J., Rosa, M.C., Galve-Roperh, I., Sánchez, C.,
Velasco, G., González-Feria, L. A pilot clinical study of Δ9-tetrahydrocannabinol in patients
with recurrent glioblastoma multiforme. Br. J. Cancer 95, 197-203 (2006).
Lorente, M., Torres, S., Salazar, M., Cariacedo, A., Hernández-Tiedra, S., Rodríguez-Fornés,
F., García-Taboada, E., Meléndez, B., Mollejo, M., Campos-Martín, Y., Lakatosh, S.A.,
Barcia, J., Guzmán, M. & Velasco, G. Stimulation of the midkine/ALK axis renders glioma
cells resistant to cannabinoid anti-tumoral action. Cell Death Differ. Epub ahead of print
(2011).
Nomura, D.K., Long, J.Z., Niessen, S., Hoover, H.S., Ng, S.W., Cravatt, B.F. Monoacylglycerol
lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140, 49-61
(2010).
Salazar, M., Carrracedo, A., Salanueva, I., Hernández, S., Blázquez, C., Lorente, M., Egia, A.,
Vázquez, P., Torres, S., Garcia, S., Nowak, J., Fimia, G.M., Piacentini, M., Cecconi, F.,
Pandolfi, P.P., González-Feria, L., Iovanna, J.L., Guzmán, M., Boya, P., Velasco, G.
Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress
in human glioma cells. J. Clin. Invest. 119, 1359-1372 (2009).
Sarfaraz, S., Adhami, V.M., Syed, D.N., Afaq, F., Mukhtar, H. Cannabinoids for cancer
treatment: progress and promise. Cancer Res. 68, 339-422 (2008).
Torres, S., Lorente, M., Rodríguez-Fornés, F., Hernández-Tiedra, S., Salazar, M., GarcíaTaboada, E., Barcia, J., Guzmán, M., Velasco, G. A combined preclinical therapy of
cannabinoids and temozolomide against glioma. Mol. Cancer Ther. 10, 90-103 (2011).
Velasco, G., Carracedo, A., Blázquez, C., Lorente, M., Aguado, T., Haro, A., Sánchez, C.,
Galve-Roperh, I., Guzmán, M. Cannabinoids and gliomas. Mol. Neurobiol. 36, 60-72 (2007).
Wang, D., Wang, H., Ning, W., Backlund, M.G., Dey, S.K., DuBois, R.N. Loss of cannabinoid
receptor 1 accelerates intestinal tumor growth. Cancer Res. 68, 6468-6476 (2008).